Skip to main content

Table 1 Patient and tumour characteristics ( n =192)

From: Invasive lobular carcinoma of the breast: long-term prognostic value of Ki67 and histological grade, alone and in combination with estrogen receptor

Variables No (%)
Age (years)  
  Median (range) 62 (36–87)
Menopausal status  
  Premenopausal 48 (26)
  Postmenopausal 138 (74)
  Unknown 6
Type of surgery  
  BCSa (no ALNDb) 4 (2)
  BCS + ALND 36 (19)
  Mastectomy (no ALND) 7 (4)
  Mastectomy + ALND 145 (76)
Tumour size (mm)  
  pT1 (≤20) 108 (57)
  pT2 (>20 and ≤50) 69 (37)
  pT3 (>50) 12 (6)
  Undefined 3
Nodal status c  
  pN- (ALND) 106 (59)
  cN- (no ALND) 11
  pN+ 75 (41)
  pN1 (1-3+) 36 (20)
  pN2 (4-9+) 28 (16)
  pN3 (>9+) 11 (6)
Pathological stage d  
  I 78 (42)
  II 68 (36)
  III 42 (22)
  IV 0 (0)
  Undefined (but not stage IV) 4
Adjuvant therapy e  
  RT (total) 93 (48)
  CT (total) 5 (3)
  ET (total) 78 (41)
  RT (monotherapy) 39 (20)
  CT (monotherapy) 3 (12)
  ET (monotherapy) 27 (14)
  RT+CT 3 (2)
  RT+ET 51 (27)
  CT+ET 0 (0)
  RT+CT+ET 0 (0)
  1. aBCS: Breast conserving surgery.
  2. bALND: Axillary lymph node dissection.
  3. cc = clinical, p = pathological, N- = node negative, N+ = node positive.
  4. dPathological stage: I = pT1-2N0M0, II = T2-3N0, M0 T1-2N1M0,
  5. III = pT3N1M0, pT1-3N2M0, T4N0-2M0, T1-4N3M0,
  6. IV = T1-4N0-3M1.
  7. eAdjuvant therapy: RT = radiotherapy, CT = chemotherapy, ET = endocrine therapy.